Loading institutional data...
Loading institutional data...
Institutional distribution: ownership decreased -0.74% quarter-over-quarter.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $7.19 today, the market must believe free cash flow compounds 6.6%/yr for a decade (off $18M normalized FCF).
The market's 6.6% is more optimistic than its 9-yr track record.
2-stage DCF · 0.03B shares · net debt $128M
mean -1255.8% · volatility σ 2728% · implied rate exceeded in 2/5 yrs
Central path = implied 6.6%/yr growth; shaded band = ±1σ (2728%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Ranked against 490 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMZN | $2.70T | — | — | — | — | — | — | 20.5% | 16.2% | — | 5,764 |
| TSLA | $1.37T | 339.1× | 145.5× | 14.5× | -2.9% | 18.0% | 4.0% | 4.6% | 4.2% | 0.9× | 4,029 |
| TM | $614.2B | 60.0× | 24.8× | 2.6× | 3.8% | 18.4% | 4.4% | 7.9% | 5.9% | 1.7× | 665 |
| PDD | $442.6B | 32.9× | 31.9× | 7.2× | 14.5% | 56.3% | 22.7% | 23.7% | 23.7% | — | 548 |
| HD | $301.3B | 21.3× | 14.3× | 1.8× | 3.2% | 33.3% | 8.6% | 110% | 22.8% | 2.0× | 3,970 |
| BABA | $201.7B | 135.7× | — | 1.4× | 8.1% | 39.8% | 10.1% | 9.8% | 9.8% | — | 1,298 |
| TJX | $140.1B | 26.0× | — | 2.3× | 7.1% | 31.0% | 9.1% | 53.9% | 42.1% | — | 2,608 |
| HTHT | $132.7B | 187.9× | 114.3× | — | — | — | — | 39.7% | 27.3% | 0.7× | 258 |
| SBUX | $109.9B | 59.3× | 26.8× | 3.0× | 2.8% | — | 5.0% | -22.9% | 23.3% | 3.4× | 2,252 |
| LOW | $108.9B | 16.4× | 12.0× | 1.3× | 3.1% | 33.5% | 7.7% | -67.1% | 22.3% | 3.2× | 2,591 |
| ABNB | $101.7B | — | 37.9× | 8.3× | 10.3% | 83.0% | 20.5% | 30.6% | 24.6% | 0.8× | 1,246 |
| MELI | $92.5B | 46.3× | — | 3.2× | 39.1% | 44.5% | 6.9% | 29.6% | 12.5% | — | 1,380 |
| MAR | $88.8B | 35.1× | 20.6× | 3.4× | 4.3% | — | 9.9% | -69.0% | -69.4% | 0.0× | 1,559 |
| LKNCY | $86.3B | 168.2× | 90.8× | 12.3× | 48.9% | — | 7.3% | 23.0% | 23.0% | — | 9 |
| GM | $78.3B | 26.5× | 3.9× | 0.4× | -1.3% | — | 1.5% | 4.4% | 4.4% | — | 1,447 |
| ROST | $74.0B | 34.7× | 22.0× | 3.3× | 7.7% | 27.7% | 9.4% | 34.7% | 27.8% | 0.5× | 1,276 |
| ORLY | $71.5B | 28.6× | 19.5× | 4.0× | 6.4% | 51.6% | 14.3% | -333% | 48.3% | 1.5× | 1,569 |
| HLT | $69.7B | 49.4× | 24.0× | 5.8× | 7.7% | — | 12.1% | -27.0% | -27.0% | — | 1,126 |
| RCL | $67.7B | 16.0× | — | 3.8× | 8.8% | 49.4% | 23.8% | 42.5% | 32.3% | — | 1,114 |
| SE | $62.0B | 40.2× | 24.6× | 2.7× | 36.4% | 44.7% | 6.9% | 12.6% | 12.6% | — | 718 |
| F | $54.2B | — | 4.5× | 0.3× | 1.2% | 6.8% | -4.4% | -22.7% | -22.7% | — | — |
| NKE | $53.9B | 17.3× | — | 1.2× | 0.2% | 42.9% | 6.7% | 20.9% | 13.6% | — | 1,848 |
| EBAY | $50.7B | 26.0× | 18.4× | 4.6× | 7.9% | 71.5% | 18.3% | 45.3% | 38.8% | 0.3× | 1,182 |
| AZO | $47.8B | 19.6× | 13.3× | 2.5× | 2.4% | 52.6% | 13.2% | -73.2% | 46.4% | 2.1× | 1,245 |
| CMG | $44.8B | 29.4× | 19.4× | 3.8× | 5.4% | — | 12.9% | 54.3% | 54.3% | 0.0× | 1,203 |
| SRI | $201M | — | — | 0.2× | -5.2% | 19.9% | -11.9% | -57.2% | -28.5% | -29.6× | 110 |
Peers = companies sharing SRI's sector (Consumer Cyclical) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Insufficient balance-sheet detail (needs retained earnings, working capital, equity).
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on $12M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -29%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $53M covers the $14M due within a year 3.8× over. Scheduled principal only (excludes interest & revolver draws). As of 2015-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~6.7% on $194M of debt. Interest last disclosed in FY2023 (no longer broken out).
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
No standout strengths flagged.
Where each multiple sits in its own 14-yr range · 18th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 70.4 | 74.4 | 76.2 | 78.3 | 80.6 | 79.4 | 79.2 | 80.1 |
| R&D | 5.9 | 6.3 | 7.6 | 8.6 | 7.3 | 7.3 | 7.9 | 7.3 |
| SG&A | 16.0 | 14.8 | 17.4 | 15.1 | 11.9 | 12.0 | 12.9 | 14.6 |
| Operating Income | 7.7 | 8.5 | -1.2 | 2.0 | 0.3 | 1.3 | -0.0 | -4.5 |
| Income Tax | 1.3 | 1.0 | -0.4 | 1.2 | 0.4 | 0.3 | 0.3 | 5.5 |
| Net Income | 6.2 | 7.2 | -1.2 | 0.4 | -1.6 | -0.5 | -1.8 | -11.9 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on SRI: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $861.3M 100.0% | $908.3M 100.0% | $975.8M 100.0% | $899.9M 100.0% | $770.5M 100.0% | $648.0M 100.0% | $834.3M 100.0% | $866.2M 100.0% | $824.4M 100.0% | $696.0M 100.0% |
| Cost of Revenue | $690.1M 80.1% | $719.0M 79.2% | $774.5M 79.4% | $725.0M 80.6% | $603.6M 78.3% | $493.8M 76.2% | $620.6M 74.4% | $609.6M 70.4% | $576.3M 69.9% | $500.5M 71.9% |
| Cost of Products | — | — | — | — | — | — | — | — | $576.3M 69.9% | $500.5M 71.9% |
| Research & Development | $62.5M 7.3% | $72.2M 7.9% | $71.1M 7.3% | $65.3M 7.3% | $66.2M 8.6% | $49.4M 7.6% | $52.2M 6.3% | $51.1M 5.9% | $48.9M 5.9% | $40.2M 5.8% |
| Selling, General & Admin | $125.6M 14.6% | $117.5M 12.9% | $117.4M 12.0% | $106.7M 11.9% | $116.0M 15.1% | $112.5M 17.4% | $123.9M 14.8% | $138.6M 16.0% | $141.9M 17.2% | $111.1M 16.0% |
| Operating Income | -$38.6M -4.5% | -$381K -0.0% | $12.8M 1.3% | $2.9M 0.3% | $15.4M 2.0% | -$7.7M -1.2% | $71.3M 8.5% | $67.0M 7.7% | $57.4M 7.0% | $44.1M 6.3% |
| Interest Expense | — | — | -$13.0M -1.3% | -$7.1M -0.8% | -$5.2M -0.7% | — | — | — | — | — |
| Other Income (Expense), net | -$3.6M -0.4% | $2.5M 0.3% | -$1.2M -0.1% | -$5.7M -0.6% | -$1.4M -0.2% | $1.5M 0.2% | -$142K -0.0% | $736K 0.1% | -$641K -0.1% | $147K 0.0% |
| Pretax Income | -$55.5M -6.4% | -$13.6M -1.5% | -$1.9M -0.2% | -$10.7M -1.2% | $12.4M 1.6% | -$10.7M -1.7% | $68.4M 8.2% | $65.1M 7.5% | $52.6M 6.4% | $39.2M 5.6% |
| Income Tax Expense | $47.4M 5.5% | $2.9M 0.3% | $3.3M 0.3% | $3.4M 0.4% | $9.0M 1.2% | -$2.8M -0.4% | $8.1M 1.0% | $11.2M 1.3% | $7.5M 0.9% | -$36.4M -5.2% |
| Net Income | -$102.8M -11.9% | -$16.5M -1.8% | -$5.2M -0.5% | -$14.1M -1.6% | $3.4M 0.4% | -$8.0M -1.2% | $60.3M 7.2% | $53.8M 6.2% | $45.2M 5.5% | $77.5M 11.1% |
| Per Share | ||||||||||
| EPS (Basic) | $-3.70 | $-0.60 | $-0.19 | $-0.52 | $0.13 | $-0.29 | $2.17 | $1.90 | $1.61 | $2.79 |
| EPS (Diluted) | $-3.70 | $-0.60 | $-0.19 | $-0.52 | $0.12 | $-0.29 | $2.13 | $1.85 | $1.57 | $2.74 |
| Weighted Avg Shares (Basic) | 27.8M | 27.6M | 27.4M | 27.3M | 27.1M | 27.0M | 27.8M | 28.4M | 28.1M | 27.8M |
| Weighted Avg Shares (Diluted) | 27.8M | 27.6M | 27.4M | 27.3M | 27.4M | 27.0M | 28.3M | 29.1M | 28.8M | 28.3M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.